Advertisement
Advertisement

EVAX

EVAX logo

Evaxion A/S - ADR

4.34
USD
Sponsored
+0.27
+6.63%
May 08, 15:57 UTC -4
Closed
exchange

After-Market

4.42

+0.08
+1.82%

Evaxion A/S - ADR Profile

About

Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.

Info & Links

CEO

Christian Kanstrup

Headquarters

Dr. Neergaards Vej 5F
Hoersholm, G7 2970, DENMARK

Industry

Medical Info Systems

Sector

Medical

Website

www.evaxion-biotech.com

Auditor

EY Godkendt Revisionspartnerselskab

Share holders

--

Employees

49

Evaxion A/S - ADR Statistics

Valuation Measures

Market Capitalization2

36.86M

Enterprise Value

21.13M

Enterprise Value/EBITDA(ttm)

-16.04

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.01

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-3248.78%

Return on Equity(ttm)

-61.43%

Return on Invested Capital(ttm)

-24.11%

Return on Assets(ttm)

-29.14%

Income Statement

Revenue(ttm)

7.53M

Revenue Per Share(ttm)

0.90

Gross Profit(ttm)

7.53M

EBITDA(ttm)3

-1.32M

Net Income Available to Common(ttm)

-1.79M

Diluted EPS(ttm)

-1.32

Share Statistics

Beta (5Y Monthly)

0.19

52-Week Change

199.31%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

8.34M

Dividend Yield

0.00%

Float4

4.87M

% Held by Insiders

41.64%

% Held by Institutions

11.04%

Balance Sheet

Total Cash(mrq)

23.23M

Total Cash Per Share(mrq)

2.79

Total Debt(mrq)

7.50M

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

5.85%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement